BRIEF published on 02/27/2025 at 10:43, 1 year 6 months ago ZEISS VISUMAX 800 Gains China Approval Regulatory Approval China Market ZEISS VISUMAX 800 Femtosecond Laser Surgical Enhancement
PRESS RELEASE published on 02/27/2025 at 10:38, 1 year 6 months ago ZEISS VISUMAX 800 with SMILE pro software receives approval in China ZEISS VISUMAX 800 with SMILE pro software receives approval in China, providing faster treatment, flexibility, and workflow enhancements for refractive surgeons ZEISS VISUMAX 800 Femtosecond Laser SMILE Pro Software China Approval Refractive Surgeons
BRIEF published on 02/12/2025 at 07:03, 1 year 7 months ago Carl Zeiss Meditec annonce une croissance modeste de son chiffre d'affaires pour le premier trimestre 2024/25 Carl Zeiss Meditec Croissance Des Revenus Ophtalmologie Premier Trimestre 2024/25 Performances Mondiales
BRIEF published on 02/12/2025 at 07:03, 1 year 7 months ago Carl Zeiss Meditec Reports Modest Revenue Growth for Q1 2024/25 Revenue Growth Carl Zeiss Meditec Ophthalmology Q1 2024/25 Global Performance
PRESS RELEASE published on 02/12/2025 at 06:58, 1 year 7 months ago Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 Carl Zeiss Meditec reports slight revenue growth of +3.2% in the first three months of fiscal year 2024/25, driven by order entry and order backlog recovery Revenue Growth Carl Zeiss Meditec Q1 Results 2024/25 Fiscal Year DORC Acquisition
BRIEF published on 12/11/2024 at 07:05, 1 year 9 months ago Carl Zeiss Meditec fait face à une baisse de son chiffre d'affaires au cours d'un exercice fiscal difficile Carl Zeiss Meditec Baisse Des Revenus Exercice 2023/24 Climat D’investissement Mondial Ophtalmologie Et Microchirurgie
BRIEF published on 12/11/2024 at 07:05, 1 year 9 months ago Carl Zeiss Meditec Faces Revenue Decline Amidst Challenging Fiscal Year Revenue Decline Carl Zeiss Meditec Fiscal Year 2023/24 Global Investment Climate Ophthalmology And Microsurgery
PRESS RELEASE published on 12/11/2024 at 07:00, 1 year 9 months ago Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved Carl Zeiss Meditec ends fiscal year 2023/24 with slight revenue decline but achieves adjusted EBIT forecast despite challenging economic conditions Revenue Decline Carl Zeiss Meditec Fiscal Year 2023/24 Adjusted EBIT Forecast Challenging Economic Conditions
BRIEF published on 08/06/2024 at 07:05, 2 years 1 month ago Carl Zeiss Meditec annonce une légère baisse de ses revenus pour les neuf premiers mois de 2023/24 Marge EBIT Baisse Des Revenus Ophtalmologie Performance Régionale Microchirurgie
BRIEF published on 08/06/2024 at 07:05, 2 years 1 month ago Carl Zeiss Meditec Reports Slight Revenue Decline for First Nine Months of 2023/24 EBIT Margin Revenue Decline Ophthalmology Regional Performance Microsurgery
Published on 09/12/2026 at 02:35, 11 hours 35 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 10 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 5 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 45 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 10 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 39 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 55 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 59 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 25 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 54 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
